Beremans comprises a core group supported by a number of Associates. This enables the company to build project teams specific to the needs of a given assignment. Core personnel and Associates have significant, long-term experience in the Life Sciences sector, which enables them to bring real value to clients. Relevant experience of Beremans personnel and Associates includes positions in many Life Science-related organisations and support companies, including Arthur Andersen, Cambridge Antibody Technology, Deutsche Bank, Glaxo Wellcome, Imperial Cancer Research Fund, Scientific Generics, Sirus Pharmaceuticals, Technical Investment Services Limited, The Technology Partnership and Wellcome.
Within these organisations, Beremans personnel have worked in a variety of functions providing direct experience of the drug discovery, development and commercialisation process, from a ‘hands-on’ level in the laboratory to senior corporate development and licensing functions and board representation. In addition, the network of personal contacts derived from many years spent working in this sector allows Beremans to bring a unique perspective to Life Sciences investment research.
In general, Beremans does not make public the identities of its clients, nor of the companies that are analysed on behalf of clients. Such confidentiality helps all parties to feel comfortable in the execution of sometimes sensitive projects. Nevertheless, many clients are willing to provide references in response to bona fide enquiries relating to the quality of Beremans’ services. Interested parties should contact Beremans directly for further information.